Decision of the fine-tuning dataset by leveraging a dynamic set of inputs, including efficacy, delivery rate and toxicology data analysis from structural,Invitro, animal model and human database and etc. of the right data at the right time, and takes a holistic view at minimizing total cost
We do this by designing, building and scaling cutting-edge drug development assessment platform and potential development solutions that align investment to business strategy, enable people to trust the go to market models that support them, and meet you at your current state, no matter your current skills or technical footprint. It takes all of it to de-risk and then accelerate a drug journey.